NASDAQ:PTGX | Cash Flow Statement | Protagonist Therapeutics, Inc

Complete source-backed cash-flow history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$162.85M
2026-03-31$3.78M$407,000.00-$48.94M$215,000.00$90.89M$23.37M
2025-12-31-$44.38M$376,000.00-$36.98M$144,000.00$48.82M$2.84M
2025-09-30-$39.34M
2025-06-30-$34.77M
2025-03-31-$11.66M$239,000.00$125.36M$545,000.00-$94.4M$11.44M
2024-12-31$131.67M$118,000.00-$29.18M$310,000.00-$8.73M$4.03M
2024-09-30-$33.21M
2024-06-30-$30.62M
2024-03-31$207.34M$236,000.00-$27.43M$242,000.00$6.07M$7.2M
2023-12-31$27.34M$248,000.00$16.96M$19,000.00-$61.29M$527,000.00
2023-09-30-$34.11M
2023-06-30-$38.46M
2023-03-31-$33.73M$248,000.00-$34.35M$10,000.00$9.83M$26.46M
2022-12-31-$34.19M$256,000.00-$31.64M$70,000.00$3.94M$553,000.00
2022-09-30-$31.23M
2022-06-30-$41.04M
2022-03-31-$20.93M$249,000.00-$37.67M$273,000.00-$4.48M$16.93M
2021-12-31-$36.91M-$26.94M$196,000.00$27.87M$2.17M
2021-09-30-$33.8M
2021-06-30-$30.84M
2021-03-31-$24M$180,000.00-$28.76M$140,000.00-$6.79M$979,000.00
2020-12-31-$18.89M$347,000.00-$18.87M$125,000.00-$74.4M$126.98M
2020-09-30-$7.76M
2020-06-30-$19.42M
2020-03-31-$20.08M$217,000.00-$15.85M$138,000.00$42.73M$399,000.00
2019-12-31-$17.5M$231,000.00-$14.29M$218,000.00-$12.55M$9.78M
2019-09-30-$16.41M
2019-06-30-$29.17M
2019-03-31-$14.1M$130,000.00-$16.66M$166,000.00$4.11M$390,000.00
2018-12-31-$13.87M$128,000.00-$10.14M$62,000.00$4.55M$479,000.00
2018-09-30-$8.74M
2018-06-30-$8.66M
2018-03-31-$7.66M$78,000.00-$15.14M$208,000.00-$21.84M$530,000.00
2017-12-31-$3.05M$117,000.00-$14.15M$56,000.00$4.75M$65.06M
2017-09-30-$4.83M
2017-06-30-$14.98M
2017-03-31-$14.1M$88,000.00-$10.36M$48,000.00-$1.25M$374,000.00
2016-12-31-$11.25M$75,000.00-$9.68M$52,000.00
2016-09-30-$7.08M
2016-06-30-$7.1M
2016-03-31-$11.75M$73,000.00-$5.24M$251,000.00
2015-12-31-$5.49M$87,000.00-$4.74M$220,000.00
2015-09-30-$3.45M
2015-06-30-$3.22M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$130.15M$1.28M$57.67M$1.59M-$49.33M$22.86M
2024-12-31$275.19M$826,000.00$184.15M$1.36M-$299.48M$25.85M
2023-12-31-$78.96M$977,000.00-$70.24M$609,000.00-$39.26M$170.48M
2022-12-31-$127.39M$1.03M-$108.14M$795,000.00$91.47M$18.84M
2021-12-31-$125.55M$813,000.00-$107.87M$1.1M-$15.86M$129.92M
2020-12-31-$66.15M$948,000.00-$72.48M$471,000.00-$90.97M$247.63M
2019-12-31-$77.19M$732,000.00-$41.53M$967,000.00-$53.71M$46.04M
2018-12-31-$38.92M$527,000.00-$49.95M$486,000.00$2.21M$24.12M
2017-12-31-$36.96M$406,000.00$3.87M$666,000.00$15.82M$65.55M
2016-12-31-$37.18M$317,000.00-$29.97M$347,000.00-$59.33M$106.31M
2015-12-31-$14.86M$247,000.00-$14.39M$399,000.00-$8.26M$17.42M
2014-12-31-$11.07M$258,000.00-$7.74M$299,000.00